OF NOTE THIS WEEK
According to a new study by two Stanford University professors, PEPFAR cut the AIDS death toll in its African target countries by more than 10 percent, but did not prevent new cases, the New York Times reports. The assessment, which was published on Monday in the Annals of Internal Medicine, analyzed UNAIDS data from the five years before PEPFAR's launch and the four years after, comparing 12 African countries that had received PEPFAR assistance with 29 that had not.
“Treatment has worked,” said study author Eran Bendavid in an interview with Bloomberg. "The challenge now is to make prevention “a serious component of the program in the next five years.”
NEWS AND HIGHLIGHTS FROM THE DONORS
- The Global Fund publishes a progress report on its second replenishment
- The Global Fund publishes an updated demand estimate for 2008-2010
OTHER NEWS AND HIGHLIGHTS
- PEPFAR Is Found to Reduce Deaths from AIDS, but Not New Cases, in Africa (NY Times)
- Early Use of AIDS Drugs Cuts Patients’ Risk of Death (Bloomberg)
- Guilty Verdict in First-Ever Murder Trial for Sexual HIV Transmission (Aidsmap)
- Uganda: Company Asked Not to Export AIDS Drugs (New Vision)
- Uganda: First Lady Calls for More HIV/AIDS Prevention for Unborn Babies (New Vision)
- 'Dead Aid,' Dead Wrong (Washington Post)
